Additional file 1: of Survey of e-learning implementation and faculty support strategies in a cluster of mid-European medical schools

The questionnaire, which served as a survey instrument (the text was translated from German into English). It was made available to the addressed medical schools in Austria, Germany and Switzerland with the online program SurveyMonkeyÂŽ (SurveyMonkey, Oregon, USA). The survey consisted of 49 items, with 27 closed questions and 22 questions for free text answers. (DOCX 30 kb

Additional file 2: of Survey of e-learning implementation and faculty support strategies in a cluster of mid-European medical schools

Original answers (n  = 21) of the participating medical schools to the question “Which challenges do you see in the field of e-learning for your medical school in the next years?” (This was translated from German into English.) Each number represents commentaries of one medical school (anonymous). (DOCX 23 kb

Prevalence and Nature of Clinically Significant Drug Interactions in Kenya.

<p> <b>*occurring in 334 individuals.</b></p

Risk of Clinically Significant Drug Interaction by Individual Drug.

<p> <b><i>‡: Fisher exact test.</i></b></p

Odds Ratios for Clinically Significant Drug Interaction by CD4 Count Decile.

<p>Odds Ratios for Clinically Significant Drug Interaction by CD4 Count Decile.</p

Factors Associated with Risk for Developing a Clinically Significant Drug Interaction.

<p>Summary statistics are based on original data (ignoring the missing observations). However, both the unadjusted (univariate) and adjusted (bivariate) odds ratios (and their 95% confidence intervals) were computed after a multiple imputation analysis (of 100 iterations) to replace the missing observations for age, CD4 count, weight and WHO Stage. The odds ratios were computed using logistic regression models (with all variables forced into the model in the adjusted/multivariate analysis).</p><p> <i>*: missing observations replaced using multiple imputation (100 iterations).</i></p

Demographic and clinical characteristics^a.

a<p>Values are expressed as No. (%) or median (interquartile range).</p>b<p>Standardized T scores based on normative data.</p>c<p>Previous or current disease involving the CNS, psychiatric disorder, psychopharmacologic treatment, and drug use.</p><p>Abbreviations: MSM, men who have sex with men; CDC, Centers for Disease Control and Prevention; ARV, antiretroviral; PIs, protease inhibitors; NRTIs, nucleoside reverse transcriptase inhibitors; NNRTIs, nonnucleoside reverse transcriptase inhibitors; LPV/r, lopinavir/ritonavir; LPV/r-MT, lopinavir/ritonavir monotherapy; LPV/r-ART, lopinavir/ritonavir triple-therapy; TDF, tenofovir; FTC, emtricitabine; ABC, abacavir, 3TC, lamivudine; AZT, zidovudine; ddI, didanosine; VL, viral load; WAIS-III, Wechsler Adult Intelligence Scale-III; Beck Depression Inventory; STAI, State-Trait Anxiety Inventory.</p